TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer said he wouldn’t be surprised if Allergan looked at buying Anacor before Pfizer decided to acquire the company for $5.2 billion, including debt. Cramer said, ‘the area of atopic dermatitis is a crowded field. I think people have to recognize that Pfizer may have decided that we have to buy someone. This is a very unusual acquisition because Pfizer has been building up its cancer franchise.’
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
